Evidence map›Paper›PMID 36447909›Full record

ArticleClinical liver disease2022

Treatment of hepatitis C in primary health care in the country of Georgia.

Ekaterine Dolmazashvili, Lali Sharvadze, Akaki Abutidze, Nikoloz Chkhartishvili, Manana Todua, Ekaterine Adamia, Tamar Gabunia, Shaun Shadaker, Lia Gvinjilia, Sanjeev Arora and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical liver disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ekaterine DolmazashviliHepatology Department Hepatology Clinic "HEPA" Tbilisi Georgia.
Lali SharvadzeHepatology Department Hepatology Clinic "HEPA" Tbilisi Georgia.
Akaki AbutidzeIvane Javakhishvili Tbilisi State University Tbilisi Georgia.
Nikoloz ChkhartishviliAIDS Outpatient Department Infectious Diseases, AIDS & Clinical Immunology Research Center Tbilisi Georgia.
Manana ToduaIvane Javakhishvili Tbilisi State University Tbilisi Georgia.
Ekaterine AdamiaHealth Policy Department Ministry of Labour, Health and Social Affairs of Georgia Tbilisi Georgia.
Tamar GabuniaHealth Policy Department Ministry of Labour, Health and Social Affairs of Georgia Tbilisi Georgia.
Shaun ShadakerDivision of Viral Hepatitis National Center for HIV, Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention Atlanta Georgia USA.
Lia GvinjiliaThe Task Force for Global Health Tbilisi Georgia.
Sanjeev AroraUniversity of New Mexico Albuquerque New Mexico USA.
Karla ThorntonUniversity of New Mexico Albuquerque New Mexico USA.
Paige A ArmstrongDivision of Viral Hepatitis National Center for HIV, Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention Atlanta Georgia USA.
Tengiz TsertsvadzeHepatology Department Hepatology Clinic "HEPA" Tbilisi Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Content available: Audio Recording.

Identifiers

PMID36447909
PMCPMC9700050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.